Naryzhny S N, Legina O K
Institute of Biomedical Chemistry, Moscow, Russia; Petersburg Institute of Nuclear Physics B.P. Konstantinova National Research Center "Kurchatov Institute", Gatchina, Russia.
Petersburg Institute of Nuclear Physics B.P. Konstantinova National Research Center "Kurchatov Institute", Gatchina, Russia.
Biomed Khim. 2021 Mar;67(2):105-118. doi: 10.18097/PBMC20216702105.
Haptoglobin (Hp) is a blood plasma glycoprotein that binds free hemoglobin (Hb) and plays a critical role in tissue protection and the prevention of oxidative damage. In addition, it has a number of regulatory functions. Haptoglobin is an acute phase protein, its concentration in plasma changes in pathology, and the test for its concentration is part of normal clinical practice. Haptoglobin is a conservative protein synthesized mainly in the liver and lungs and is the subject of research as a potential biomarker of many diseases, including various forms of malignant neoplasms. Haptoglobin has several unique biophysical characteristics. Only in humans, the Hp gene is polymorphic, has three structural alleles that control the synthesis of three major phenotypes of Hp, homozygous Hp1-1 and Hp2-2, and heterozygous Hp2-1, determined by a combination of allelic variants that are inherited. Numerous studies indicate that the phenotype of haptoglobin can be used to judge the individual's predisposition to various diseases. In addition, Hp undergoes various post-translational modifications (PTMs). These are structural transformations (removal of the signal peptide, cutting of the Pre-Hp precursor molecule into two subunits, α and β, limited proteolysis of α-chains, formation of disulfide bonds, multimerization), as well as chemical modifications of α-chains and glycosylation of the β-chain. Glycosylation of the β-chain of haptoglobin at four Asn sites is the most important variable PTM that regulates the structure and function of the glycoprotein. The study of modified oligosaccharides of the Hp β-chain has become the main direction in the study of pathological processes, including malignant neoplasms. Many studies are focused on the identification of PTM and changes in the level of the α2-chain of this protein in pathology. These characteristics of Hp indicate the possibility of the existence of this protein as different proteoforms, probably with different functions. This review is devoted to the description of the structural and functional diversity of Hp and its potential use as a biomarker of various pathologies.
触珠蛋白(Hp)是一种血浆糖蛋白,它能结合游离血红蛋白(Hb),在组织保护和预防氧化损伤中起关键作用。此外,它还具有多种调节功能。触珠蛋白是一种急性期蛋白,其血浆浓度在病理状态下会发生变化,检测其浓度是正常临床实践的一部分。触珠蛋白是一种主要在肝脏和肺中合成的保守蛋白,作为包括各种恶性肿瘤在内的多种疾病的潜在生物标志物,它是研究的对象。触珠蛋白具有几个独特的生物物理特性。仅在人类中,Hp基因具有多态性,有三个结构等位基因控制Hp三种主要表型的合成,即纯合子Hp1-1和Hp2-2,以及杂合子Hp2-1,它们由遗传的等位基因变体组合决定。大量研究表明,触珠蛋白的表型可用于判断个体对各种疾病的易感性。此外,Hp会经历各种翻译后修饰(PTM)。这些修饰包括结构转变(信号肽的去除、Pre-Hp前体分子切割成α和β两个亚基、α链的有限蛋白水解、二硫键的形成、多聚化),以及α链的化学修饰和β链的糖基化。触珠蛋白β链在四个天冬酰胺位点的糖基化是调节糖蛋白结构和功能的最重要可变PTM。对Hpβ链修饰寡糖的研究已成为包括恶性肿瘤在内的病理过程研究的主要方向。许多研究集中于鉴定该蛋白在病理状态下的PTM和α2链水平的变化。Hp的这些特性表明该蛋白可能以不同的蛋白异构体形式存在,可能具有不同的功能。这篇综述致力于描述Hp的结构和功能多样性及其作为各种病理状态生物标志物的潜在用途。